Elevance Health, Inc. Hits New 52-Week High at $421.00

Elevance Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 421.00 on June 8, 2026. This achievement marks a notable point in the company's performance within the healthcare services industry, where it operates as a large-cap entity with a market capitalization of USD 63,208 million. Despite the recent high, Elevance Health's one-year performance reflects a decline of 22.02%, contrasting sharply with the S&P 500's gain of 23.42% over the same period. The company's price-to-earnings (P/E) ratio stands at 11.00, indicating its valuation relative to earnings, while its price-to-book ratio is recorded at 1.44. Additionally, Elevance Health offers a dividend yield of 2.46%, providing a return to its shareholders. With a debt-to-equity ratio of -0.09 and a return on equity of 12.90%, Elevance Health's financial metrics present a comprehensive view of its current standing in the market. The stock's previous 52-week low was USD 273.71, highlighting the significant upward movement it has experienced recently.